Literature DB >> 15557500

Natural history of nonketotic hyperglycinemia in 65 patients.

J E Hoover-Fong1, S Shah, J L K Van Hove, D Applegarth, J Toone, A Hamosh.   

Abstract

BACKGROUND: Glycine encephalopathy, also known as nonketotic hyperglycinemia (NKH), is an autosomal recessive disorder caused by a defect in the glycine cleavage system. NKH is classically associated with neonatal apnea, lethargy, hypotonia, and seizures, followed by severe psychomotor retardation in those who survive.
METHODS: To determine the natural history of NKH, the authors mailed a 44-question survey to 170 households in the International NKH Family Network.
RESULTS: Data for 65 patients (36 boys, 29 girls) were collected from 58 families. One-third of the subjects died; 8 girls died during the neonatal period, and 14 patients died thereafter (2 girls, 12 boys). Median age of death for boys was 2.6 years vs <1 month for girls (p = 0.02). Mean birth weight and length, occipitofrontal circumference, and gestation duration were normal. Two-thirds of infants were ventilated during the neonatal period; of these, 40% died. Ninety percent had confirmed seizures, 75% during the first month of life. Interestingly, three NKH patients never developed seizures. An abnormal corpus callosum and/or hydrocephalus were associated with especially poor gross motor and speech development. Of 25 patients living > or =3 years, 10 were able to walk and say/sign words; all were boys. In six families with more than one affected child, disease course and mortality were similar within each family.
CONCLUSIONS: This study reveals a striking and unexpected gender difference in mortality and developmental progress. Of the two-thirds of nonketotic hyperglycinemia patients surviving the newborn period, up to 20% (mostly boys) may learn to walk and communicate by saying or signing words.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557500     DOI: 10.1212/01.wnl.0000144270.83080.29

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

1.  Benzoate treatment and the glycine index in nonketotic hyperglycinaemia.

Authors:  J L K Van Hove; K Vande Kerckhove; J B Hennermann; V Mahieu; P Declercq; S Mertens; M De Becker; P S Kishnani; J Jaeken
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Prediction of long-term outcome in glycine encephalopathy: a clinical survey.

Authors:  Julia B Hennermann; Jeanne-Marie Berger; Ulrike Grieben; Gunter Scharer; Johan L K Van Hove
Journal:  J Inherit Metab Dis       Date:  2011-10-15       Impact factor: 4.982

3.  The effect of hyperglycinemic treatment in captive-bred Vervet monkeys (Chlorocebus aethiops).

Authors:  Zandisiwe E Magwebu; Mikateko Mazinu; Sahar Abdul-Rasool; Chesa G Chauke
Journal:  Metab Brain Dis       Date:  2019-06-22       Impact factor: 3.584

4.  [Clinical and molecular genetic characteristics of nonketotic hyperglycinemia].

Authors:  Hai-Feng Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-03

5.  Glycine receptors support excitatory neurotransmitter release in developing mouse visual cortex.

Authors:  Portia A Kunz; Alain C Burette; Richard J Weinberg; Benjamin D Philpot
Journal:  J Physiol       Date:  2012-09-17       Impact factor: 5.182

6.  Mutation analysis of glycine decarboxylase, aminomethyltransferase and glycine cleavage system protein-H genes in 13 unrelated families with glycine encephalopathy.

Authors:  Nor Azimah Abdul Azize; Wan Zurinah Wan Ngah; Zulhabri Othman; Norsiah Md Desa; Chen Bee Chin; Zabedah Md Yunus; Anand Mohan; Teh Siao Hean; Syed Zulkifli Syed Zakaria; Ngu Lock-Hock
Journal:  J Hum Genet       Date:  2014-09-18       Impact factor: 3.172

Review 7.  Treatable Genetic Metabolic Epilepsies.

Authors:  Lama Assi; Youssef Saklawi; Pascale E Karam; Makram Obeid
Journal:  Curr Treat Options Neurol       Date:  2017-09       Impact factor: 3.598

8.  Two Novel GLDC Mutations in a Neonate with Nonketotic Hyperglycinemia.

Authors:  Sarah L Nickerson; Shanti Balasubramaniam; Philippa A Dryland; Jennifer M Love; Maina P Kava; Donald R Love; Debra O Prosser
Journal:  J Pediatr Genet       Date:  2016-06-15

9.  Musculoskeletal manifestations of neonatal nonketotic hyperglycinemia.

Authors:  Norman Ramirez; John M Flynn; Francisco Casalduc; Stephanie Rodriguez; Alberto S Cornier; Simón Carlo
Journal:  J Child Orthop       Date:  2012-05-25       Impact factor: 1.548

10.  Genomic deletion within GLDC is a major cause of non-ketotic hyperglycinaemia.

Authors:  Junko Kanno; Tim Hutchin; Fumiaki Kamada; Ayumi Narisawa; Yoko Aoki; Yoichi Matsubara; Shigeo Kure
Journal:  J Med Genet       Date:  2007-03       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.